Quantinno Capital Management LP Has $27.83 Million Stock Holdings in ICU Medical, Inc. $ICUI

Posted by George Bondi on Aug 1st, 2026

Quantinno Capital Management LP decreased its stake in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 22.7% in the 1st quarter, Holdings Channel.com reports. The fund owned 215,490 shares of the medical instruments supplier’s stock after selling 63,217 shares during the quarter. Quantinno Capital Management LP’s holdings in ICU Medical were worth $27,831,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Hilton Head Capital Partners LLC bought a new stake in ICU Medical during the fourth quarter worth about $32,000. Covestor Ltd boosted its position in ICU Medical by 22.1% during the fourth quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock valued at $99,000 after purchasing an additional 126 shares during the last quarter. Strs Ohio grew its stake in ICU Medical by 60.0% in the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 300 shares in the last quarter. Rockefeller Capital Management L.P. grew its stake in ICU Medical by 21.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 146 shares in the last quarter. Finally, Kemnay Advisory Services Inc. acquired a new position in shares of ICU Medical during the 4th quarter worth approximately $120,000. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insider Activity at ICU Medical

In related news, Director David C. Greenberg sold 2,424 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the transaction, the director directly owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. The trade was a 23.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,447 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $124.08, for a total value of $303,623.76. Following the transaction, the vice president directly owned 19,460 shares in the company, valued at $2,414,596.80. The trade was a 11.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 2.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Zacks Research cut ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Weiss Ratings raised shares of ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 23rd. Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Jefferies Financial Group upgraded shares of ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Finally, Sanford C. Bernstein lowered shares of ICU Medical to a “market perform” rating in a research report on Monday, June 15th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $172.00.

Check Out Our Latest Research Report on ICU Medical

ICU Medical Trading Up 0.1%

ICU Medical stock opened at $168.51 on Friday. ICU Medical, Inc. has a 52 week low of $107.00 and a 52 week high of $170.81. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 2.34. The stock has a market capitalization of $4.21 billion, a P/E ratio of 91.09, a PEG ratio of 2.35 and a beta of 0.76. The stock has a 50-day simple moving average of $148.01 and a 200 day simple moving average of $140.30.

ICU Medical (NASDAQ:ICUI – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, topping analysts’ consensus estimates of $1.78 by $0.19. The firm had revenue of $525.77 million for the quarter, compared to the consensus estimate of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The business’s revenue was down 12.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.72 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Analysts expect that ICU Medical, Inc. will post 6.51 earnings per share for the current year.

ICU Medical Company Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.